143 related articles for article (PubMed ID: 38531511)
1. Benefits of NSAIDs plus Pancreatic Stenting to Prevent Post-ERCP Pancreatitis.
Hanscom M
Gastroenterology; 2024 Mar; ():. PubMed ID: 38531511
[No Abstract] [Full Text] [Related]
2. Efficacy of pancreatic duct stenting to prevent postendoscopic retrograde cholangiopancreatography pancreatitis after covered self-expandable metal stent deployment.
Toyonaga H; Hayashi T; Yamazaki H; Hama K; Iwano K; Nakamura R; Ando R; Shimizu T; Ishii T; Kin T; Takahashi K; Katanuma A
Dig Endosc; 2023 Mar; 35(3):369-376. PubMed ID: 36129765
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
5. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial.
Ito K; Fujita N; Noda Y; Kobayashi G; Obana T; Horaguchi J; Takasawa O; Koshita S; Kanno Y; Ogawa T
J Gastroenterol; 2010 Nov; 45(11):1183-91. PubMed ID: 20607310
[TBL] [Abstract][Full Text] [Related]
6. Preventing Post-ERCP Pancreatitis: The Role of Prophylactic Pancreatic Duct Stenting in the Rectal NSAID Era.
Bekkali NL; Thomas T; Keane MG; Murray S; Joshi D; Elsayed G; Johnson GJ; Chapman MH; Pereira SP; Webster GJM
JOP; 2017 Jul; 18(4):316-319. PubMed ID: 29731700
[TBL] [Abstract][Full Text] [Related]
7. Universal prophylactic rectal nonsteroidal anti-inflammatory drugs with a policy of selective pancreatic duct stenting significantly reduce post-endoscopic retrograde cholangiopancreatography pancreatitis.
Agarwal A; Mahapatra SJ; Sethia R; Agarwal S; Elhence A; Mohta S; Gunjan D; Garg PK
Indian J Gastroenterol; 2023 Jun; 42(3):370-378. PubMed ID: 37160838
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial.
Conigliaro R; Manta R; Bertani H; Manno M; Barbera C; Caruso A; Olivetti G; Melotti G; Frazzoni M
Surg Endosc; 2013 Feb; 27(2):569-74. PubMed ID: 22926890
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitis.
Sakai Y; Tsuyuguchi T; Yokosuka O
World J Clin Cases; 2014 Sep; 2(9):426-31. PubMed ID: 25232545
[TBL] [Abstract][Full Text] [Related]
10. Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Sperna Weiland CJ; Engels MML; Poen AC; Bhalla A; Venneman NG; van Hooft JE; Bruno MJ; Verdonk RC; Fockens P; Drenth JPH; van Geenen EJM;
Dig Dis Sci; 2021 Dec; 66(12):4457-4466. PubMed ID: 33630216
[TBL] [Abstract][Full Text] [Related]
11. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial.
Phillip V; Pukitis A; Epstein A; Hapfelmeier A; Haf D; Schwab M; Demir IE; Rosendahl J; Hoffmeister A; Schmid RM; Weber A; Algül H
Endosc Int Open; 2019 Jul; 7(7):E860-E868. PubMed ID: 31281872
[No Abstract] [Full Text] [Related]
13. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
[TBL] [Abstract][Full Text] [Related]
14. Rescue ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series.
Madácsy L; Kurucsai G; Joó I; Gódi S; Fejes R; Székely A
Surg Endosc; 2009 Aug; 23(8):1887-93. PubMed ID: 19057957
[TBL] [Abstract][Full Text] [Related]
15. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?
Parsi MA
World J Gastroenterol; 2012 Aug; 18(30):3936-7. PubMed ID: 22912542
[TBL] [Abstract][Full Text] [Related]
16. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
Smeets XJNM; da Costa DW; Fockens P; Mulder CJJ; Timmer R; Kievit W; Zegers M; Bruno MJ; Besselink MGH; Vleggaar FP; van der Hulst RWM; Poen AC; Heine GDN; Venneman NG; Kolkman JJ; Baak LC; Römkens TEH; van Dijk SM; Hallensleben NDL; van de Vrie W; Seerden TCJ; Tan ACITL; Voorburg AMCJ; Poley JW; Witteman BJ; Bhalla A; Hadithi M; Thijs WJ; Schwartz MP; Vrolijk JM; Verdonk RC; van Delft F; Keulemans Y; van Goor H; Drenth JPH; van Geenen EJM;
Trials; 2018 Apr; 19(1):207. PubMed ID: 29606135
[TBL] [Abstract][Full Text] [Related]
17. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis.
Njei B; McCarty TR; Muniraj T; Sharma P; Jamidar PA; Aslanian HR; Varadarajulu S; Navaneethan U
Endosc Int Open; 2020 Jan; 8(1):E29-E40. PubMed ID: 31921982
[No Abstract] [Full Text] [Related]
20. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
